Krueger JG - Search Results

1

Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases.

Johnson-Huang LM, McNutt NS, Krueger JG, Lowes MA. Johnson-Huang LM, et al. Among authors: krueger jg. J Clin Immunol. 2009 May;29(3):247-56. doi: 10.1007/s10875-009-9278-8. Epub 2009 Feb 28. J Clin Immunol. 2009. PMID: 19252974 Free PMC article. Review.

2

Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.

Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J. Smoller BA, et al. Arch Dermatol. 1990 Jan;126(1):78-83. Arch Dermatol. 1990. PMID: 1688702

3

"Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.

Smoller BR, Krueger J, McNutt NS, Hsu A. Smoller BR, et al. Mod Pathol. 1990 Mar;3(2):171-5. Mod Pathol. 1990. PMID: 1691494

4

Fixed drug eruptions: evidence for a cytokine-mediated process.

Smoller BR, Luster AD, Krane JF, Krueger J, Gray MH, McNutt NS, Hsu A, Gottlieb AB. Smoller BR, et al. J Cutan Pathol. 1991 Feb;18(1):13-9. doi: 10.1111/j.1600-0560.1991.tb00596.x. J Cutan Pathol. 1991. PMID: 1827131

5

Detection of the interferon-gamma-induced protein 10 in psoriasiform dermatitis of acquired immunodeficiency syndrome.

Smoller BR, McNutt NS, Gray MH, Krueger J, Hsu A, Gottlieb AB. Smoller BR, et al. Arch Dermatol. 1990 Nov;126(11):1457-61. Arch Dermatol. 1990. PMID: 2146926

6

The immunologic basis for the treatment of psoriasis with new biologic agents.

Krueger JG. Krueger JG. J Am Acad Dermatol. 2002 Jan;46(1):1-23; quiz 23-6. doi: 10.1067/mjd.2002.120568. J Am Acad Dermatol. 2002. PMID: 11756941 Review.

7

Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.

Oliver SJ, Kikuchi T, Krueger JG, Kaplan G. Oliver SJ, et al. Among authors: krueger jg. Clin Immunol. 2002 Mar;102(3):225-36. doi: 10.1006/clim.2001.5173. Clin Immunol. 2002. PMID: 11890709

8

Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis.

Chamian F, Krueger JG. Chamian F, et al. Among authors: krueger jg. Curr Opin Rheumatol. 2004 Jul;16(4):331-7. doi: 10.1097/01.bor.0000129715.35024.50. Curr Opin Rheumatol. 2004. PMID: 15201593 Review.

9

Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin.

Vugmeyster Y, Kikuchi T, Lowes MA, Chamian F, Kagen M, Gilleaudeau P, Lee E, Howell K, Bodary S, Dummer W, Krueger JG. Vugmeyster Y, et al. Among authors: krueger jg. Clin Immunol. 2004 Oct;113(1):38-46. doi: 10.1016/j.clim.2004.06.001. Clin Immunol. 2004. PMID: 15380528

10

Current concepts in the immunopathogenesis of psoriasis.

Lowes MA, Lew W, Krueger JG. Lowes MA, et al. Among authors: krueger jg. Dermatol Clin. 2004 Oct;22(4):349-69, vii. doi: 10.1016/j.det.2004.03.010. Dermatol Clin. 2004. PMID: 15450332 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters